Cargando…

Progressive muscle proteome changes in a clinically relevant pig model of Duchenne muscular dystrophy

Duchenne muscular dystrophy (DMD) is caused by genetic deficiency of dystrophin and characterized by massive structural and functional changes of skeletal muscle tissue, leading to terminal muscle failure. We recently generated a novel genetically engineered pig model reflecting pathological hallmar...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fröhlich, Thomas, Kemter, Elisabeth, Flenkenthaler, Florian, Klymiuk, Nikolai, Otte, Kathrin A., Blutke, Andreas, Krause, Sabine, Walter, Maggie C., Wanke, Rüdiger, Wolf, Eckhard, Arnold, Georg J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5025886/ https://www.ncbi.nlm.nih.gov/pubmed/27634466 http://dx.doi.org/10.1038/srep33362

Ejemplares similares

Progressive Proteome Changes in the Myocardium of a Pig Model for Duchenne Muscular Dystrophy
por: Tamiyakul, Hathaichanok, et al.
Publicado: (2020)

A scalable, clinically severe pig model for Duchenne muscular dystrophy
por: Stirm, Michael, et al.
Publicado: (2021)

Systemic deletion of DMD exon 51 rescues clinically severe Duchenne muscular dystrophy in a pig model lacking DMD exon 52
por: Stirm, Michael, et al.
Publicado: (2023)

Isolation and Characterization of Primary DMD Pig Muscle Cells as an In Vitro Model for Preclinical Research on Duchenne Muscular Dystrophy
por: Donandt, Tina, et al.
Publicado: (2022)

A decade of experience with genetically tailored pig models for diabetes and metabolic research
por: Zettler, Silja, et al.
Publicado: (2020)

Genome editing for Duchenne muscular dystrophy: a glimpse of the future?
por: Kupatt, Christian, et al.
Publicado: (2021)

Genetically modified pigs as donors of cells, tissues, and organs for xenotransplantation
por: Wolf, Eckhard, et al.
Publicado: (2019)

Differential Effects of Insulin-Deficient Diabetes Mellitus on Visceral vs. Subcutaneous Adipose Tissue—Multi-omics Insights From the Munich MIDY Pig Model
por: Flenkenthaler, Florian, et al.
Publicado: (2021)

Mitochondrial Dysregulation Secondary to Endoplasmic Reticulum Stress in Autosomal Dominant Tubulointerstitial Kidney Disease – UMOD (ADTKD-UMOD)
por: Kemter, Elisabeth, et al.
Publicado: (2017)

Recent developments in Duchenne muscular dystrophy: facts and numbers
por: Walter, Maggie C., et al.
Publicado: (2017)

Time to diagnosis of Duchenne muscular dystrophy in Austria and Germany
por: Hiebeler, Miriam, et al.
Publicado: (2023)

Survival in Duchenne muscular dystrophy
por: RALL, SUSANNE, et al.
Publicado: (2012)

Theragnosis for Duchenne Muscular Dystrophy
por: Luce, Leonela, et al.
Publicado: (2021)

Adult care for Duchenne muscular dystrophy in the UK
por: Rodger, Sunil, et al.
Publicado: (2014)

Missense Mutation of POU Domain Class 3 Transcription Factor 3 in Pou3f3(L423P) Mice Causes Reduced Nephron Number and Impaired Development of the Thick Ascending Limb of the Loop of Henle
por: Rieger, Alexandra, et al.
Publicado: (2016)

Hypokalemia complicating Duchenne muscular dystrophy.
por: McDonald, B., et al.
Publicado: (1987)

The role of fibrosis in Duchenne muscular dystrophy
por: KLINGLER, WERNER, et al.
Publicado: (2012)

Delay in Diagnosis of Duchenne Muscular Dystrophy
por: Rao, Vamshi K., et al.
Publicado: (2015)

Circulating Biomarkers for Duchenne Muscular Dystrophy
por: Aartsma-Rus, Annemieke, et al.
Publicado: (2015)

Targeting angiogenesis in Duchenne muscular dystrophy
por: Podkalicka, Paulina, et al.
Publicado: (2019)

Regenerative biomarkers for Duchenne muscular dystrophy
por: Guiraud, Simon, et al.
Publicado: (2019)

Eteplirsen in the treatment of Duchenne muscular dystrophy
por: Lim, Kenji Rowel Q, et al.
Publicado: (2017)

Nutritional Challenges in Duchenne Muscular Dystrophy
por: Salera, Simona, et al.
Publicado: (2017)

Lifetime Care of Duchenne Muscular Dystrophy
por: MacKintosh, Erin W., et al.
Publicado: (2020)

The Duchenne muscular dystrophy gene and cancer
por: Jones, Leanne, et al.
Publicado: (2020)

CRISPR Therapeutics for Duchenne Muscular Dystrophy
por: Erkut, Esra, et al.
Publicado: (2022)

Exon-Skipping in Duchenne Muscular Dystrophy
por: Takeda, Shin’ichi, et al.
Publicado: (2021)

Gene Therapy for Duchenne Muscular Dystrophy
por: Elangkovan, Nertiyan, et al.
Publicado: (2021)

Family reflections: Duchenne Muscular Dystrophy
por: Gill, Omaira
Publicado: (2022)

Cardiac therapies for Duchenne muscular dystrophy
por: Shah, Md Nur Ahad, et al.
Publicado: (2023)

Newborn screening for Duchenne muscular dystrophy‐early detection and diagnostic algorithm for female carriers of Duchenne muscular dystrophy
por: Gruber, Dorota, et al.
Publicado: (2022)

Effect of Yoga and Ayurveda on Duchenne Muscular Dystrophy
por: Telles, Shirley, et al.
Publicado: (2011)

Symptomatic therapy of Duchenne Muscular Dystrophy (DMD)
por: Rüdel, Reinhardt
Publicado: (2012)

Presence of mechanical dyssynchrony in duchenne muscular dystrophy
por: Hor, Kan N, et al.
Publicado: (2011)

Understanding the Process of Fibrosis in Duchenne Muscular Dystrophy
por: Kharraz, Yacine, et al.
Publicado: (2014)

Duchenne muscular dystrophy: Advances in molecular appraoch
por: Benitto, Afaf, et al.
Publicado: (2013)

Left ventricular noncompaction in Duchenne muscular dystrophy
por: Statile, Christopher J, et al.
Publicado: (2013)

Vascular-targeted therapies for Duchenne muscular dystrophy
por: Ennen, James P, et al.
Publicado: (2013)

Characterization of pulmonary function in Duchenne Muscular Dystrophy
por: Mayer, O.H., et al.
Publicado: (2015)

Optimizing Bone Health in Duchenne Muscular Dystrophy
por: Buckner, Jason L., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_629bo15ororllstqtq28bn7fss